IP Library Granted Patent US 8,945,862
Granted Patent B2
US 8,945,862 · App. 13/358,838 · Granted Feb 3, 2015

Triple-fusion constructs and methods of monitoring human embryonic stem cells

Inventors: Joseph Ching-Ming Wu (Palo Alto, CA); Feng Cao (San Jose, CA); Sanjiv Sam Gambhir (Porollo Valley, CA)
Assignee: The Board of Trustees of the Leland Stanford Junior University
C12N5/0606C12N5/0603C12N5/0657C12N5/069A61K35/12C12N2506/02C12N2510/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,945,862
App. No.
13/358,838
Granted
Feb 3, 2015
Kind
B2
Abstract

Embodiments of the present disclosure include triple-fusion human embryonic stem cells, methods of imaging triple-fusion human embryonic stem cells, triple-fusion polynucleotides, triple-fusion proteins, methods of monitoring the progression of human embryonic stem cells, methods of making isolated triple-fusion human embryonic stem cells, and the like.

Claims (28)

1. A method of monitoring human embryonic stem cells (hESCs) comprising:

providing human embryonic stem cells;

transducing the hESCs with a triple-fusion expression vector to produce triple-fusion hESCs, wherein the triple-fusion expression vector comprises a firefly luciferase reporter gene (Fluc) having a nucleotide sequence selected from the group consisting of: SEQ ID NO: 1 and SEQ ID NO: 3, a red fluorescent reporter gene (RFP) having a nucleotide sequence of SEQ ID NO: 6, and a truncated HSV1-tK positron emission tomography (PET) reporter gene (HSV1-tTK) having a nucleotide sequence selected from the group consisting of: SEQ ID NO: 7 and SEQ ID NO: 14; and

detecting fluorescence, bioluminescence, a nuclear signal from a PET reporter, or a combination thereof, emitted from the triple-fusion hESCs and any progeny of the triple-fusion hESCs.

2. The method of claim 1 , wherein the expression vector is LV-pUP-Fluc-RFP-tTK, where LV is lentivirus, pUP is constitutive human ubiquitin promoter, Fluc is firefly luciferase reporter gene, RFP is the red fluorescent reporter gene, and tTK is the truncated HSV1-tk PET reporter gene.

3. The method of claim 1 , wherein the triple-fusion expression vector comprises a gene having SEQ ID NO: 8.

4. The method of claim 1 , wherein the triple-fusion expression vector comprises a gene encoding a triple-fusion protein having SEQ ID NO: 9.

5. The method of claim 1 , wherein the triple-fusion expression vector comprises a gene encoding a triple-fusion protein having SEQ ID NO: 18.

6. A method of monitoring human embryonic stem cells (hESCs) in a subject comprising:

providing triple-fusion hESCs having a triple-fusion expression vector comprising a firefly luciferase reporter gene (Fluc) having a nucleotide sequence selected from the group consisting of: SEQ ID NO: 1 and SEQ ID NO: 3, a red fluorescent reporter gene (RFP) having a nucleotide sequence of SEQ ID NO: 6, and a truncated HSV1-tK positron emission tomography (PET) reporter gene (HSV1-tTK) having a nucleotide sequence selected from the group consisting of: SEQ ID NO: 7 and SEQ ID NO: 14;

administering the triple-fusion hESCs to the subject; and

detecting fluorescence, bioluminescence, a nuclear signal from a PET reporter, or a combination thereof, emitted from the triple-fusion hESCs and any progeny of the triple-fusion hESCs.

7. The method of claim 6 , wherein the expression vector is LV-pUP-Fluc-RFP-tTK, where LV is lentivirus, pUP is constitutive human ubiquitin promoter, Fluc is firefly luciferase reporter gene, RFP is the red fluorescent reporter gene, and tTK is the truncated HSV1-tk PET reporter gene.

8. The method of claim 6 , wherein the triple-fusion expression vector comprises a gene having SEQ ID NO: 8.

9. The method of claim 6 , wherein the triple-fusion expression vector comprises a gene encoding a triple-fusion protein having SEQ ID NO: 9.

10. The method of claim 6 , wherein the triple-fusion expression vector comprises a gene encoding a triple-fusion protein having SEQ ID NO: 18.

11. A triple-fusion construct comprising:

a firefly luciferase reporter gene (Fluc) having a nucleotide sequence selected from the group consisting of: SEQ ID NO: 1 and SEQ ID NO:3;

a red fluorescent reporter gene (RFP) having a nucleotide sequence SEQ ID NO: 6; and a truncated Herpes Simplex Virus 1 thymidine kinase positron emission tomography (PET) reporter gene (HSV1-tTK) having a nucleotide sequence selected from the group consisting of: SEQ ID NO: 7 and SEQ ID NO: 14.

12. A method of monitoring stem cells comprising:

providing stem cells;

transducing the stem cells with a triple-fusion expression vector to produce triple-fusion stem cells, wherein the triple-fusion expression vector comprises a firefly luciferase reporter gene (Fluc) having a nucleotide sequence selected from the group consisting of: SEQ ID NO: 1 and SEQ ID NO: 3, a red fluorescent reporter gene (RFP) having a nucleotide sequence of SEQ ID NO: 6, and a truncated HSV1-tK positron emission tomography (PET) reporter gene (HSV1-tTK) having a nucleotide sequence selected from the group consisting of: SEQ ID NO: 7 and SEQ ID NO: 14; and

detecting fluorescence, bioluminescence, a nuclear signal from a PET reporter, or a combination thereof, emitted from the triple-fusion stem cells and any progeny of the triple-fusion stem cells.

13. The method of claim 12 , wherein the stem cells are human stem cells.

14. A method of monitoring human stem cells in a subject comprising:

providing triple fusion human stem cells having a triple-fusion expression vector comprising a firefly luciferase reporter gene (Fluc) having a nucleotide sequence selected from the group consisting of: SEQ ID NO: 1 and SEQ ID NO: 3, a red fluorescent reporter gene (RFP) having a nucleotide sequence of SEQ ID NO: 6, and a truncated HSV1-tK positron emission tomography (PET) reporter gene (HSV1-tTK) having a nucleotide sequence selected from the group consisting of: SEQ ID NO: 7 and SEQ ID NO: 14;

administering the triple-fusion human stem cells to the subject; and

detecting fluorescence, bioluminescence, a nuclear signal from a PET reporter, or a combination thereof, emitted from the triple-fusion human stem cells and any progeny of the triple-fusion human stem cells.

Assignments (2)
CONFIRMATORY LICENSE Recorded Apr 11, 2012
From: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 028027/0775 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 22, 2012
From: WU, JOSEPH CHING-MING; CAO, FENG; GAMBHIR, SANJIV SAM
To: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Reel/Frame 027740/0448 →
Continuity (3)
Division 12315873 · Dec 4, 2008
Provisional Application 60992136 · Dec 4, 2007
Related Publication 20120144506A1 · Jun 7, 2012